期刊文献+

血管狭窄性脑缺血患者血浆半乳糖凝聚素-3水平及其与血管狭窄程度及预后的关系 被引量:1

Relationship of plasma galectin-3 level with angiostenosis severity and prognosis in patients with angiostenosis-related cerebral ischemia
下载PDF
导出
摘要 目的探讨血管狭窄性脑缺血患者血浆半乳糖凝聚素-3(galectin-3)水平及其与血管狭窄程度及患者预后的关系。方法将86例血管狭窄性脑缺血患者(观察组)按血管狭窄程度分成轻、中、重度狭窄组,选择同期30名健康志愿者为对照组,检测并比较各组血浆galectin-3表达水平,采用改良Rankin残障量表(mRS)对86例患者脑缺血预后进行评估。分析观察组患者galectin-3水平与脑血管狭窄程度、脑缺血预后评分的相关性。采用受试者工作特征(ROC)曲线评估galectin-3对脑缺血患者预后的预测价值。结果观察组血浆galectin-3水平高于对照组(P<0.05)。轻、中、重度狭窄组血浆galectin-3水平依次升高(P<0.05)。脑缺血患者预后mRS评分<3分者血浆galectin-3水平低于评分≥3分者(P<0.05),且患者血浆galectin-3水平与脑血管狭窄程度及预后mRS评分均呈正相关(P<0.05)。血浆galectin-3水平预测脑缺血预后的ROC曲线下面积为0.756(P<0.001)。结论 Galectin-3可能参与了血管狭窄性脑缺血的发生及发展,其对血管狭窄性脑缺血患者的预后有一定预测价值。 Objective To investigate the relationship of plasma galectin-3 level with angiostenosis severity and prognosis in patientswith angiostenosis-related cerebral ischemia. Methods Eighty-six patients(observation group) with cerebral ischemia due to angiostenosiswere divided into mild, moderate and severe stenosis groups according to the severity of angiostenosis. Conwere enrolled in the control group. The expression levels of plasma galectin-3 were detected and compared among aRankin Handicap Scale (mRS) was used to evaluate the prognosis of the 86 patients with cerebral ischemia. The correlation of galectin-3level with the severity of cerebral angiostenosis or the prognosis score of cerebral ischemiaoperating characteristic( ROC) curve was used to evaluate the value of galectin-3 in predicting the prognosis of patients with cerebral ischemia.Results The level of plasma galectin-3 in the observation group was higher than that in the control group ( P 〈 0. 05). The plasma galectin-3 levels increased in the order of the mild, moderate and severe stenosis groups ( P 〈 0. 05 ). Among patients with cerebral ischemia, the plasma galectin-3 level of patients witli mRS score 〈 3 was lower than that of patients with mRS score 〉 or = 3( P〈0. 05 ), and the plasma galectin-3 level positively correlated witli angiostenosis severity and mRS score of prognosis ( P 〈0. 0 5 ) . The area of ROC curve of plasma galectin-3 level for predicting the prognosis of cerebral ischemia was 0.756(P 〈0.001). Conclusion Galectin-3 might and development of angiostenosis-related cerebral ischemia,and has a certain value in predicting the prognosiscerebral ischemia.
出处 《广西医学》 CAS 2017年第12期1823-1826,共4页 Guangxi Medical Journal
关键词 脑缺血 血管狭窄 半乳糖凝聚素-3 预后 Cerebral ischemia, Angiostenosis, Galectin-3 , Prognosis
  • 相关文献

参考文献2

二级参考文献20

  • 1Papaspyridonos M, McNeill E, de Bono JP, et al. Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction. Arterioscler Thromb Vasc Biol, 2008, 28: 433-440.
  • 2Falcone C, Lucibello S, Mazzucchelli 1, et al. Galectin3 plasma levels and coronary artery disease: a new possible biomarker of acute coronary syndrome. Int J Immunopathol Pharmacol. 2011, 24: 905-913.
  • 3Lok DJA, Van Der Meer P, Lipsic E, et al. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin Res Cardiol, 2010, 99: 323-328.
  • 4Chert K, Jiang RJ, Wang CQ, et al. Predictive value of plasma galectin-3 in patients with chronic heart failure. Eur Rev Med Pharmacol Sci, 2013, 17: 1005-1011.
  • 5Felker GM, Fiuzat M, Shaw LK, et al. Galectin-3 in ambulatory patients with heart failure results from the HF-ACTION study. Circ Heart Fail, 2012, 5: 72-78.
  • 6Tufi6n J, Blanco-Colio L, Crist6bal C, et al. Usefulness of a Combination of Monocyte Chemoattractant Protein-1, Galectin-3, and N-Terminal Probrain Natriuretic Peptide to Predict Cardiovascular Events in Patients With Coronary Artery Disease. Am J Cardiol, 2014, 113: 434-440.
  • 7Grandin EW, Jarolim P, Murphy SA, et al. Galectin-3 and the development of heart fmlure after acute coronaiy syndrome: Pilot experience from PROVE IT-TIMI 22. Clin Chem, 2012, 58: 267-273.
  • 8Von Hundelshausen P, Weber C. Chronic inflammation and atherosclerosis. Dtsch Med Wochenschr, 2013, 138: 839-844.
  • 9Arar C, Gaudin JC, Capron L, et al. Galectin-3 gene (LGALS3) expression in experimental atherosclerosis and cultured smooth muscle cells. FEBS letters, 1998, 430:307-311.
  • 10Nachtigal M, A1-Assaad Z, Mayer EP, et al. Galectin-3 expression in human atherosclerotic lesions. Am J Pathol, 1998, 152:1199.

共引文献25

同被引文献16

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部